CTCXCarmell Therapeutics Corp - Ordinary Shares - Class A

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$450,780.00
Vol3,065.00
News
all
press releases
News Placeholder
Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off
From acquisition news and FDA designations to fresh optimism for struggling stocks, these biotechs piqued Stocktwits users the most on the first trading day of 2025.
Stocktwits
<
...
1
>
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.